Pharma Research
Avecho and Sandoz Ink 10-Year Deal for Australia’s First Pharmaceutical CBD Capsule for Insomnia
Avecho and Sandoz sign an exclusive ten-year development and license agreement ("Agreement") for Avecho's pharmaceutical cannabidiol capsule for insomnia...
March 04, 2025 | News
MojiaBio and A*STAR Partner to Develop SGD 44.8 Million Sustainable Biomanufacturing Technology Platform in Singapore
MojiaBio, a global leader in green chemistry and sustainable biomanufacturing, has announced a strategic partnership with the Agency for Science, Technolog...
March 03, 2025 | News
China Fapon Biopharma secures US FDA IND approval for FP008 a first-in-class immunocytokine for resistant solid tumors
Fapon Biopharma, a biotech innovator in developing therapeutic antibodies and fusion proteins, is pleased to announce that the U.S. Food and Drug Administr...
March 03, 2025 | News
Neopharma Partners with AusChain to Enable Blockchain-Powered Drug Test Kit Traceability
Neopharma Technologies Ltd (Neopharma) is pleased to announce a strategic partnership with AusChain Pty Ltd, a global leader in scalable blockchain so...
February 28, 2025 | News
Alphamab Oncology and CSPC Dose First Patient in Phase III Trial of JSKN003 for HER2-Positive Breast Cancer
Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that the first patient has...
February 28, 2025 | News
Metabolon Expands Multiomics Biomarker Discovery with New Integrated Bioinformatics Capabilities
Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic dev...
February 28, 2025 | News
Kangpu Biopharma Secures China IND Approval for KPG-818 in Relapsed/Refractory Multiple Myeloma
Kangpu Biopharmaceuticals, Ltd. ("Kangpu") announced that the Company has received IND approval from the CDE (Center for Drug Evaluation) of China National...
February 26, 2025 | News
HBM Alpha Therapeutics Secures $395M Licensing Deal to Advance CRH-Targeting Therapy
HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated by Harbour BioMed (HKEX: 02142), announced a strategic collaborati...
February 26, 2025 | News
LabConnect and ACL Specialised Trials Partner to Strengthen Clinical Trial Support in Australia and APAC
LabConnect and Australian Clinical Labs' (ACL) Specialised Trials have forged a strategic partnership to expand support of clinical trials in Aus...
February 25, 2025 | News
Chime Biologics and Mabgeek Advance MG-K10 to U.S. Phase III Trials for Atopic Dermatitis and Asthma
Chime Biologics, a leading global CDMO that enables its partners' success in biologics, announced its continued collaboration with Mabgeek ...
February 24, 2025 | News
BioMed X Launches Research Hub in Barbados to Advance Cardiometabolic Disease Treatment for Individuals of African Descent
BioMed X Institute, in collaboration with the Government of Barbados and the European Commission, is launching BioMed X Barbados, a new rese...
February 21, 2025 | News
Nona Biosciences Partners with UAB to Advance B Cell Research Using H2L2 Harbour Mice®
Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to I™), announced a licensing agreement with ...
February 20, 2025 | News
NERLYNX® Approved in Thailand for Early and Advanced HER2+ Breast Cancer Treatment
NERLYNX® (neratinib) has been approved as a single agent for the treatment of early-stage HER2+ breast cancer, and in combination with capecitab...
February 18, 2025 | News
Duke and Duke-NUS Award Over S$1 Million for Climate and Health Research in Landmark Collaboration
The two institutions awarded more than S$1 million to accelerate five promising areas of research collaboration Dedicated Research Collaborati...
February 17, 2025 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
